Simply Solventless Concentrates Ltd. Stock
Stocks
HASH
CA82888A1021
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Toronto S.E.
2026-11-02
|
5-day change | 1st Jan Change | ||
| 0.0450 CAD | 0.00% |
|
0.00% | -67.86% |
| Market Cap | 5.2M 3.72M 3.32M 3.05M 2.77M 352M 5.3M 36.4M 14.67M 186M 13.96M 13.66M 587M | P/E 2024 |
-10x | P/E 2025 | -0.58x |
|---|---|---|---|---|---|
| Enterprise Value | 22.2M 15.89M 14.19M 13.02M 11.84M 1.5B 22.64M 155M 62.67M 794M 59.63M 58.36M 2.51B | EV / Sales 2024 |
6.8x | EV / Sales 2025 | 1.14x |
| Free-Float |
80.79% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| HASH | End-of-day quote | |
OTC Markets
| SSLCF | Delayed | |
|
Deutsche Boerse AG
| Y3I | Delayed |
| 3 months | -18.18% | ||
| Current year | -67.86% |
| 1 week | 0.04 |  | 0.04 |
| 1 month | 0.04 | | 0.06 |
| Current year | 0.04 | | 0.19 |
| 1 year | 0.04 | | 0.24 |
| 3 years | 0.04 | | 0.84 |
| 5 years | 0.04 | | 0.84 |
| 10 years | 0.04 | | 0.84 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/10/26 | Buy | Director | 5,500 | 0.0057% | ||
| 2/10/26 | Buy | Director | 5,000 | 0.0052% | ||
| 2/10/26 | Buy | Director | 9,500 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -80.43% | -82.69% | 3.72M | |
| +1.47% | +10.31% | +63.52% | +143.15% | 1,257B | |
| -0.37% | +1.60% | +43.25% | +80.09% | 651B | |
| +0.09% | +0.73% | +32.47% | +101.62% | 510B | |
| -0.40% | -0.75% | +52.60% | +66.91% | 388B | |
| -1.52% | +5.51% | +72.55% | +44.25% | 366B | |
| +0.63% | +2.61% | +32.80% | +58.56% | 303B | |
| -0.04% | +8.00% | +12.00% | +34.84% | 288B | |
| -0.18% | +4.68% | +55.97% | +74.59% | 252B | |
| +0.37% | +7.34% | +42.19% | +109.69% | 211B | |
| Average | +0.23% | +4.14% | +32.69% | +63.10% | 422.67B | |
| Weighted average by Cap. | +0.54% | +5.30% | +49.19% | +93.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.68M 9.79M 8.74M 8.02M 7.3M 927M 13.95M 95.8M 38.62M 489M 36.74M 35.96M 1.55B | 29.06M 20.8M 18.57M 17.04M 15.5M 1.97B 29.64M 204M 82.03M 1.04B 78.05M 76.39M 3.28B |
| Net income | -5.19M -3.72M -3.32M -3.05M -2.77M -352M -5.3M -36.38M -14.66M -186M -13.95M -13.66M -587M | -27.33M -19.56M -17.46M -16.02M -14.58M -1.85B -27.87M -191M -77.15M -977M -73.4M -71.84M -3.09B |
| Net Debt | 9.1M 6.51M 5.81M 5.34M 4.85M 617M 9.28M 63.73M 25.69M 325M 24.44M 23.92M 1.03B | 17M 12.17M 10.86M 9.97M 9.07M 1.15B 17.34M 119M 48M 608M 45.67M 44.7M 1.92B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-02 | $0.0450 | 0.00% | 12,208 |
| 26-10-30 | $0.0450 | 0.00% | 117,000 |
| 26-10-29 | $0.0450 | 0.00% | 1,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HASH Stock
Select your edition
All financial news and data tailored to specific country editions
